Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and ...

The updated formula for Moderna’s COVID-19 vaccine generates a 16-fold increase in antibodies neutralize the intended SARS-CoV-2 variant.

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data ...

A Florida pharmacy licensing board on Tuesday made clear that prescriptions aren’t necessary for  patients who want to get ...

The panel also reverses a vote on MMRV from the prior day and postpones a vote on a birth dose of hepatitis B vaccine.

Moderna's 2025-2026 mNEXSPIKE showed strong immune response and safety in Phase 4 trials, reinforcing FDA approval for the LP.8.1-targeting formula.

Moderna (MRNA) stock is in focus as its updated mNEXSPIKE COVID vaccine boosts antibodies 15-fold on average against the new ...

The protein-based vaccine now covers the LP.8.1 variant and can be given to adolescents aged 12 years or older who previously ...

A federal panel's ruling on COVID vaccine advisability has not changed its unavailability at most Florida pharmacies, at least not yet.

Kennedy Jr.'s hand-picked vaccine panel weakened Covid shot recommendations in the U.S., advising that all Americans consult ...

A two-day federal vaccine advisory meeting crammed with chaos, confusion, inept debate, bizarre comments, and a hot mic ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...